May 13, 2026
Retatrutide: Triple Receptor Agonist Research (2026)
Retatrutide triple agonist research: GLP-1R, GIPR, and glucagon receptor mechanisms, Phase 2 NEJM 2023 trial data, and preclinical metabolic comparisons.
RESEARCH NOTES
May 13, 2026
Retatrutide triple agonist research: GLP-1R, GIPR, and glucagon receptor mechanisms, Phase 2 NEJM 2023 trial data, and preclinical metabolic comparisons.
May 6, 2026
Explore 2026 preclinical evidence on oral GLP-1 delivery innovations—SNAC, ionic liquids, nanoparticles, and enteric coatings—all for research use only.